BioTime soars on cell aging reversal

Shares of BioTime shot up over 33 percent this morning after investors got a whiff of a newly published scientific paper in which the biotech company says it was able to reverse the aging process in cells. And scientists for the company say the work has big implications for the development of a new generation of cell-based therapies that can target age-related degenerative diseases. Report